Choroideremia Treatment Market Trends

Growth Drivers

• Growing advancement in medical technology - One of the main factors propelling the market for choroideremia treatments is advancements in healthcare technologies. Numerous advancements over the past several years have resulted in novel choroideremia therapy options. 
  
  These advancements not only expanded the pool of treatments available but also improved accessibility to them. Patients can now better manage their symptoms and improve their quality of life because of the medications' increased efficacy.
   
• Favorable government policies - Globally, governments are becoming more proactive in fostering the development and availability of treatments for rare diseases such as choroideremia. Patients now have more access to medicines and treatments that can help regulate their symptoms as a result of this assistance, which has also stimulated innovation and investment in the field.

Challenges

• Complex disease pathology - Choroideremia is caused by mutations in the CHM gene that affect the production of a protein essential for the proper function of the retina. The complex interplay between genetics, cellular processes, and visual function makes it challenging to develop effective therapies.
• Side effects and safety issues associated with the treatment.
• Limited access to specialty is another factor posing limitations on the choroideremia treatment market growth in the near future.